The shortages of certain formulations of Tubersol® brand of Tuberculin Purified Protein Derivative (tuberculin) may not be resolved before 2014.   As these medications are used in tuberculosis (TB) infection control programs, employee health programs at health care facilities and long term care facilities continue to be impacted. 

In an effort to prevent disruptions to your screening program the Division of Epidemiology and Health Planning has issued a letter to all Health Care Facility Operators and Long Term Care Administrators providing recommendations on how to continue TB screening in your facility.  Read Letter  

For your convenience, quick links from the letter are provided below:

-  2010 CDC Guidelines about IGRAs

-  QuantiFERON® - TB Gold In-Tube Test

-  T-Spot® TB Test

Please contact the Kentucky Tuberculosis Prevention and Control Program at 502-564-4276 if you or your staff have further questions about TB screening, TSTs, or BAMTs.